Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$2.50
-8.1%
$7.86
$2.46
$39.95
$1.91M0.8866,325 shs148,218 shs
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$103.22
+1.0%
$94.41
$62.83
$103.98
$72.70B1.124.25 million shs3.08 million shs
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
$67.37
-0.3%
$67.53
$49.57
$80.92
$366.49M1.2370,497 shs18,028 shs
The Westaim Co. stock logo
WED
Westaim
C$28.49
+0.7%
C$30.70
C$22.80
C$35.55
C$420.92M0.3914,620 shs28,274 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.00%-11.66%-73.29%-72.65%-92.08%
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
0.00%+3.45%+10.25%+20.16%+67.29%
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
0.00%-1.29%+0.61%+9.30%+25.64%
The Westaim Co. stock logo
WED
Westaim
0.00%-5.41%-6.56%-13.72%+606.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
1.1026 of 5 stars
3.50.00.00.01.10.00.0
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
4.836 of 5 stars
2.34.04.22.13.62.53.1
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
N/AN/AN/AN/AN/AN/AN/AN/A
The Westaim Co. stock logo
WED
Westaim
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$275.0010,900.00% Upside
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
2.57
Moderate Buy$94.38-8.56% Downside
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
2.66
Moderate Buy$67.37N/A
The Westaim Co. stock logo
WED
Westaim
0.00
N/AC$7.75-72.80% Downside

Current Analyst Ratings Breakdown

Latest PTF, WED, BK, and AIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$96.00 ➝ $100.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$97.00 ➝ $100.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$105.00 ➝ $113.00
7/16/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$95.00 ➝ $101.00
7/2/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$88.00 ➝ $90.00
6/3/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$94.00 ➝ $95.00
5/28/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$87.00 ➝ $97.00
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$146K13.08N/AN/A$0.20 per share12.50
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$39.91B1.82$8.96 per share11.52$51.35 per share2.01
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
N/AN/AN/AN/AN/AN/A
The Westaim Co. stock logo
WED
Westaim
C$10.20M41.27C$28.40 per share1.00C$3.89 per share7.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$24.00N/AN/AN/A-12,594.21%-421.73%-147.54%N/A
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$4.53B$6.5515.7613.180.9912.27%13.46%1.16%10/10/2025 (Estimated)
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
N/AN/A32.05N/AN/AN/AN/AN/A
The Westaim Co. stock logo
WED
Westaim
C$4.52MC$0.4464.46N/A44.28%7.76%7.60%N/A

Latest PTF, WED, BK, and AIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/15/2025Q2 2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$1.73$1.94+$0.21$1.93$4.80 billion$4.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
$2.122.05%N/A32.37%14 Years
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
$0.140.21%N/AN/AN/A
The Westaim Co. stock logo
WED
Westaim
C$0.180.63%N/A40.72%N/A

Latest PTF, WED, BK, and AIM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/15/2025
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
quarterly$0.532.22%7/25/20257/25/20258/7/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.05
0.75
0.75
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
0.86
0.72
0.72
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
N/AN/AN/A
The Westaim Co. stock logo
WED
Westaim
N/AN/A
27.60
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
20764,00068.74 millionNot Optionable
The Bank of New York Mellon Corporation stock logo
BK
Bank of New York Mellon
51,800705.24 million704.25 millionOptionable
Invesco Dorsey Wright Technology Momentum ETF stock logo
PTF
Invesco Dorsey Wright Technology Momentum ETF
N/A5.44 millionN/AOptionable
The Westaim Co. stock logo
WED
Westaim
3,24014.77 millionN/ANot Optionable

Recent News About These Companies

Westaim (CVE:WED) Shares Down 1% - Here's Why
Westaim nears completion of CC Capital deal
Westaim: Q4 Earnings Snapshot
Westaim Restructures and Relocates to Delaware
Westaim Shareholders Approve Major CC Capital Deal
Westaim Names New CFO Amid Strategic Expansion

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSE:AIM

$2.50 -0.22 (-8.09%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.54 +0.04 (+1.60%)
As of 08/8/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Bank of New York Mellon stock logo

Bank of New York Mellon NYSE:BK

$103.22 +1.01 (+0.99%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$103.30 +0.08 (+0.07%)
As of 08/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. The company operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and other segments. The Securities Services segment offers custody, trust and depositary, accounting, exchange-traded funds, middle-office solutions, transfer agency, services for private equity and real estate funds, foreign exchange, securities lending, liquidity/lending services, and data analytics. This segment also provides trustee, paying agency, fiduciary, escrow and other financial, issuer, and support services for brokers and investors. The Market and Wealth Services segment offers clearing and custody, investment, wealth and retirement solutions, technology and enterprise data management, trading, and prime brokerage services. This segment also provides integrated cash management solutions, including payments, foreign exchange, liquidity management, receivables processing and payables management, and trade finance and processing services. The Investment and Wealth Management segment offers investment management strategies and distribution of investment products, investment management, custody, wealth and estate planning, private banking, investment, and information management services. The Other segment engages in the provision of leasing, corporate treasury, derivative and other trading, corporate and bank-owned life insurance, renewable energy investment, and business exit services. It serves central banks and sovereigns, financial institutions, asset managers, insurance companies, corporations, local authorities and high net-worth individuals, and family offices. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

Invesco Dorsey Wright Technology Momentum ETF stock logo

Invesco Dorsey Wright Technology Momentum ETF NASDAQ:PTF

$67.37 -0.17 (-0.25%)
Closing price 08/8/2025 03:51 PM Eastern
Extended Trading
$67.26 -0.11 (-0.16%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PowerShares Dynamic Technology Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Technology Sector Intellidex Index (the Index). The Index consists of stocks of the United States technology companies. These are companies that are principally engaged in the business of providing technology-related products and services, including computer hardware and software, Internet, electronics and semiconductors, and communication technologies. The Fund will invest at least 80% of its total assets in common stocks of technology companies. The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. The Find invests in various sectors, such as computers, electronics, software, semiconductors, telecommunications and commercial services. The Fund's investment adviser is Invesco PowerShares Capital Management LLC.

Westaim stock logo

Westaim CVE:WED

C$28.49 +0.19 (+0.67%)
As of 08/8/2025 03:59 PM Eastern

The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.